BB Biotech AG
BION.SW
$0.23
Change (1 day)
$57.57
Year High
$40.86
Year Low
Categories
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Revenue of BB Biotech AG (BION.SW)
Revenue in 2023 (TTM): $-230,696,023
According to BB Biotech AG's latest financial reports the company's current revenue (TTM) is $-230,696,023. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of BB Biotech AG
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $-230,696,023 | $-230,696,023 | $-238,742,820 | $-238,742,820 | $-238,834,142 |
| 2022 | $-406,012,378 | $-406,012,378 | $-411,558,783 | $-413,554,010 | $-413,624,524 |
| 2021 | $-458,023,513 | $-458,023,513 | $-467,873,642 | $-467,873,642 | $-467,951,093 |
| 2020 | $808.3 M | $808.3 M | $799.07 M | $799.07 M | $798.99 M |
| 2019 | $792.12 M | $792.12 M | $783.18 M | $783.18 M | $783.1 M |
| 2018 | $-538,402,466 | $-538,402,466 | $-543,526,938 | $-544,782,335 | $-544,864,410 |
| 2017 | $801.16 M | $801.16 M | $795.46 M | $794.83 M | $794.74 M |
| 2016 | $-920,677,892 | $-920,677,892 | $-925,837,044 | $-927,091,285 | $-927,173,360 |
| 2015 | $762.06 M | $762.06 M | $754.94 M | $754.74 M | $754.64 M |
| 2014 | $1.71 B | $1.71 B | $1.7 B | $1.7 B | $1.7 B |
| 2013 | $1.08 B | $1.08 B | $1.08 B | $1.08 B | $1.08 B |
| 2012 | $435.6 M | $435.6 M | $428.66 M | $425.56 M | $425.21 M |
| 2011 | $-1,466,942 | $-1,466,942 | $-75,197,838 | $-75,197,838 | $-75,298,409 |
| 2010 | $1.82 M | $1.82 M | $-169,113,351 | $-169,113,351 | $-169,175,774 |
| 2009 | $62.76 M | $62.76 M | $43.27 M | $43.27 M | $42.34 M |
| 2008 | $85.33 M | $85.33 M | $52.5 M | $52.5 M | $52.43 M |
| 2007 | $ | $ | $-306,941,182 | $-306,679,930 | $-306,810,556 |
| 2006 | $367.68 M | $367.68 M | $343.66 M | $343.91 M | $343.78 M |
| 2005 | $384.55 M | $384.55 M | $367.39 M | $367.8 M | $367.59 M |
| 2004 | $246.98 M | $246.98 M | $234.49 M | $234.49 M | $234.38 M |
| 2003 | $223.7 M | $223.7 M | $207.5 M | $207.5 M | $207.31 M |